Ewing Sarcoma
📧 Sign up to get email alerts when something new happens for Ewing Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) [Phase 2]
Phase 2 clinical trial to evaluate the efficacy and safety of naxitamab in refractory Ewing sarcoma; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
This completed clinical trial evaluates quality of life in patients with lower-limb bone tumors treated with salvage surgery.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor [Phase 1]
Phase 1 trial evaluating a conditioning regimen of busulfan, melphalan, and topotecan hydrochloride followed by stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors [Phase 2]
Phase 2 trial update of haploidentical transplantation with donor natural killer cells for solid tumors; the study was terminated and result…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) [NA]
This entry reports on the MICCHADO trial, which investigates the biological characterization of high-risk childhood cancers. The sponsor is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radiation Therapy to Treat Musculoskeletal Tumors [Phase 2]
A Phase 2 clinical trial evaluating radiation therapy for musculoskeletal tumors has posted results (as of 2025-03-06). The study is current…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Ongoing clinical trial investigating prognostic factors and the role of radiotherapy in Ewing sarcoma.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma [NA]
This completed clinical trial evaluates Beta-3 adrenergic receptor as a prognostic biomarker in neuroblastoma and Ewing sarcoma.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
This clinical trial assesses the expression of Cadherin 6 (CDH6) in primary malignant bone tumors and investigates its potential use for pro…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma [Phase 2]
Clinical trial update for SM-88 as maintenance therapy in advanced Ewing's sarcoma and as salvage therapy for sarcoma (Phase 2); trial is cu…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma [Phase 1]
An international Phase I trial is evaluating dinutuximab beta in combination with VDC/IE chemotherapy for GD2-positive Ewing sarcoma. The st…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers [Phase 1, Phase 2]
Phase 1/2 trial update evaluating nivolumab plus ABI-009 (nab-rapamycin) in patients with advanced sarcoma and selected cancers, with result…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases [NA]
Clinical trial update indicates completion of a study evaluating intensity-modulated radiation therapy in younger patients with lung metasta…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-GD2 CAR T cells in pediatric patients with high-risk or relapsed/refractory neuroblastoma and other…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors [Phase 2]
Phase 2 pediatric trial evaluating palbociclib in combination with chemotherapy for recurrent or refractory solid tumors, including Ewing sa…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]
Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors [Phase 1]
Phase 1 trial completion evaluating MR-guided High Intensity Focused Ultrasound (HIFU) for relapsed or refractory pediatric solid tumors, in…
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) [Phase 1, Phase 2]
Phase 1/2 clinical trial update for PerVision, a personalized cancer vaccine for fusion-positive sarcomas, currently recruiting at Universit…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib [Phase 2]
A Phase 2 randomized trial evaluating trilaciclib to prevent chemotherapy-related myelosuppression in patients with Ewing's sarcoma is curre…
-
CLINICAL_TRIALS withdrawal · 2024-11-08Clinical Trial Update: BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases [Phase 2]
A Phase 2 study of BIO-11006 for metastatic osteosarcoma and metastatic Ewing's sarcoma with lung metastases has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: TK216 in Patients With Relapsed or Refractory Ewing Sarcoma [Phase 1, Phase 2]
Clinical trial update for TK216 in relapsed or refractory Ewing sarcoma (Phase 1/2) shows the study was terminated with results posted.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy [NA]
This clinical trial update outlines a study comparing daily 1-beam versus 2-beam proton therapy to assess toxicity and efficacy in chordoma,…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
Phase 2 update on erdafitinib for FGFR-mutant relapsed or refractory pediatric cancers enrolled in the Pediatric MATCH trial; results were p…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human study of oral TP-1287 in patients with advanced solid tumors, including specific sarcoma subtypes, has been terminate…